Ahmed ClearPath Glaucoma Drainage Device - EyeWiki
Ahmed ClearPath (New World Medical, Rancho Cucamonga, CA) is a novel valveless GDD that was approved in 2019 by the US Food and Drug Administration and was introduced in the market for the management of glaucoma. A recent survey of the American Glaucoma Society found that 17% of respondents preferred the Ahmed Clearpath as a non-valved aqueous ...
了解Ahmed青光眼阀植入术 - 知乎 - 知乎专栏
2022年9月12日 · 青光眼引流装置（Glaucoma drainage device GDD）植入和小梁切除术是用于对药物和激光治疗欠佳的青光眼的最常用手段。GDD在传统上用于高危性青光眼病例的治疗，如葡萄膜炎和新生血管性青光眼。然而，青光眼医生越…
24-Month Outcomes of Ahmed ClearPath - Dove Medical Press
2022年3月30日 · In summary, implantation of the valveless Ahmed ClearPath GDD produces significant reductions in IOP and the need for IOP-lowering medications through up to 24 months of follow-up. Advantages of ACP include its ease of use, good safety profile, and high efficacy concerning IOP and medication burden reduction.
36-Month Outcomes of Ahmed ClearPath - National Center for ...
2024年6月18日 · To evaluate the safety and effectiveness of the Ahmed ClearPath ® (ACP) 250 mm 2 glaucoma drainage device (GDD) in managing refractory primary open-angle glaucoma (POAG). This was a retrospective case series focused on adult patients diagnosed with severe POAG who underwent implantation of an ACP GDD.
2023年12月28日 · Purpose: To compare the efficacy and safety of 2 nonvalved glaucoma drainage devices (GDDs): Ahmed ClearPath (ACP) vs. Baerveldt glaucoma implant (BGI). Design: Single-center, retrospective, comparative study.
Ahmed ClearPath vs. Baerveldt Glaucoma Implant
The 2 most commonly used GDDs are the Ahmed glaucoma valve (AGV; New World Medical Inc) and the Baerveldt glaucoma implant (BGI; Advanced Medical Optics). Whereas the AGV has a built-in Venturi-based valve to prevent postoperative hypotony, the BGI is nonvalved and is typically ligated temporarily by the surgeon to allow healing around the ...
Clinical Outcomes of Ahmed ClearPath Implantation in Glaucom ... - LWW
Designed with novel features to facilitate implantation and improve safety, the Ahmed ClearPath (ACP) glaucoma drainage device (GDD) provided intraocular pressure (IOP) reduction comparable with other GDDs in eyes with refractory glaucoma in a …
Efficacy of Ahmed and Baerveldt glaucoma drainage device …
2023年7月1日 · Glaucoma drainage devices (GDD) are increasingly utilized in the management of childhood glaucoma. This systematic review and meta-analysis assesses the efficacy of first-time Ahmed or Baerveldt implantation in children. PubMed, Embase, and Cochrane Library were searched for relevant English-language, peer-reviewed literature.
Current Choices in Glaucoma Drainage Devices
2021年9月1日 · Today the most popular GDDs are the Ahmed FP7 (New World Medical), the Baerveldt Glaucoma Implant (BGI; Johnson & Johnson Vision), and the Molteno3 (Nova Eye Medical). The sizes are 184 mm 2 for the Ahmed FP7, 250 mm 2 for the BGI 250, and 350 mm 2 for the BGI 350. The Molteno3 is available in 185 mm 2 and 245 mm 2 models.
Ahmed to Baerveldt glaucoma drainage device exchange in …
2023年7月11日 · The valved Ahmed GDD tends to be more popular due to the immediate IOP lowering effect and decreased risk of post-operative hypotony compared to the non-valved Baerveldt implants. While Ahmed GDDs in children have a greater than 80% success rate at 1 year, by 5-years, success is often less than 50% [3, 16, 17].